Relevant Criteria for Selecting an Intravenous Immunoglobulin Preparation for Clinical Use

ISSN： 1173-8804

Source： BioDrugs, Vol.24, Iss.4, 2010-08, pp. : 211-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Intravenous Immunoglobulin in Multiple Sclerosis

By Achiron A.

BioDrugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 465-475

Adis International

Access to resources Recommend Favorite

Intravenous Immunoglobulin Use in Patients with Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome

By Mittmann Nicole

American Journal of Clinical Dermatology, Vol. 7, Iss. 6, 2006-01 ,pp. : 359-368

Adis International

Access to resources Recommend Favorite

The Optimum Use of Intravenous Immunoglobulin for Prophylaxis of Opportunistic Infection in HIV-Infected Adults

By Kiehl M.G. Müller C.

BioDrugs, Vol. 10, Iss. 4, 1998-10 ,pp. : 265-273

Adis International

Access to resources Recommend Favorite

Variations in Serum Hemoglobin, Albumin, and Electrolytes in Patients Receiving Intravenous Immunoglobulin Therapy: A Real Clinical Threat?

By Mignogna Michele D.

American Journal of Clinical Dermatology, Vol. 8, Iss. 5, 2007-01 ,pp. : 291-299

Adis International

Access to resources Recommend Favorite

Mechanisms of Intravenous Immunoglobulin Action in the Treatment of Autoimmune Disorders

By Larroche C.

BioDrugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 47-55

Adis International

Access to resources Recommend Favorite